Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-15 · accession 0000950170-24-129270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-20 | 2024-11-15 | GMED | Paul David C | Executive COB, Dir, 10% | M - OptEx | $24.10 | +26.0K | 26.0K | New | +$627.6K |
| D | 2024-11-20 | 2024-11-15 | GMED | Paul David C | Executive COB, Dir, 10% | M - OptEx | $0.00 | -26.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-15 | M | A | 26,042 | $24.10 | 26,042 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2024-11-15 | M | D | 26,042 | $0.00 | 0 | D | $24.10 · — to 2025-01-20 | 26,042 Class A Common Stock | (F1) These options were granted on January 20, 2015 and are fully vested. |